Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Novartis Pharmaceuticals UK Limited, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom
Desferal Vials, 500mg.
| Pharmaceutical Form |
|---|
|
A sterile, lyophilised powder available in vials containing 500mg of desferrioxamine mesilate. |
Each vial contains desferrioxamine mesilate 500mg.
| Active Ingredient | Description | |
|---|---|---|
| Deferoxamine |
Deferoxamine is a chelating agent for trivalent iron and aluminium ions. The resulting chelates are stable and non-toxic. |
| List of Excipients |
|---|
|
None present. |
Each vial contains a white to practically white lyophilisate supplied in a clear glass vial in a pack size of 10 (500 mg).
Novartis Pharmaceuticals UK Limited, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom
PL00101/0523
31 October 1997 / 12 December 2000
| Drug | Countries | |
|---|---|---|
| DESFERAL | Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Netherlands, Poland, Romania, Tunisia, Turkey, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
